🇺🇸 Corvert in United States

FDA authorised Corvert on 28 December 1995

Marketing authorisations

FDA — authorised 28 December 1995

  • Application: NDA020491
  • Marketing authorisation holder: PFIZER
  • Local brand name: CORVERT
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 1 April 2024

  • Application: ANDA204146
  • Marketing authorisation holder: AVET LIFESCIENCES
  • Status: approved

Read official source →

Corvert in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Cardiovascular approved in United States

Frequently asked questions

Is Corvert approved in United States?

Yes. FDA authorised it on 28 December 1995; FDA authorised it on 1 April 2024.

Who is the marketing authorisation holder for Corvert in United States?

PFIZER holds the US marketing authorisation.